Cagnoni M, Tarquini B, Halberg F, März W, Cornélissen G, Mainardi G, Panero C, Shinoda M, Scarpelli P, Romano S
Prog Clin Biol Res. 1987;227B:145-51.
At present, neonates are being given screening tests for relatively rare diseases, such as phenylketonuria. The time has come to give emphasis to assessing the risk for major handicapping diseases, such as coronary heart disease, stroke, and certain diseases of the kidney. Modern technology for blood pressure and heart rate monitoring and data analysis provides noninvasive means to determine when preventive measures are indicated.
目前,新生儿正在接受针对诸如苯丙酮尿症等相对罕见疾病的筛查测试。现在是时候强调评估患重大致残性疾病的风险了,比如冠心病、中风和某些肾脏疾病。用于血压和心率监测及数据分析的现代技术提供了非侵入性手段,以确定何时需要采取预防措施。